Abbott Molecular, Inc. recalls Alinity m HCV AMP kit
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Abbott has received reports of an increase in reactive negative controls and false positive results in patient samples when using the Identified Lots of Alinity m HCV AMP Kit.
- Products
-
- Alinity m HCV AMP kit
- Company
- Abbott Molecular, Inc.
- Where it was sold
-
Worldwide
Nationwide
- Barcodes
0088499904764800884999047761- Units affected
- 1,881 units
- About this recall
- Alinity m HCV AMP kit, List (REF) Numbers: a) 08N50-095 and b) 08N50-090. The Alinity m HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for use with the automated Alinity m System to detect and quantitate hepatitis C virus (HCV) RNA in human serum or plasma.